Home › Compare › NEXI vs RYLD

NEXI vs RYLD: Dividend Comparison 2026

NEXI yields 666666.67% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEXI wins by $8.275235618773884e+34M in total portfolio value
10 years
NEXI
NEXI
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full NEXI calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — NEXI vs RYLD

📍 NEXI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEXIRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEXI + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NEXI pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEXI
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, NEXI beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEXI + RYLD for your $10,000?

NEXI: 50%RYLD: 50%
100% RYLD50/50100% NEXI
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NEXI right now

NEXI
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Price Target
$3.33
+1109900.0% upside vs current
Range: $2.00 — $5.00
Altman Z
-65.0
Piotroski
2/9
RYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEXI buys
0
RYLD buys
0
No recent congressional trades found for NEXI or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEXIRYLD
Forward yield666666.67% ✓12.14%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.275235618773884e+34M$44.5K ✓
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓$2,587.35
Total dividends collected$8.275075881065991e+34M$18.8K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NEXI vs RYLD ($10,000, DRIP)

YearNEXI PortfolioNEXI Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,914$1,213.65+$66.67M → NEXI
2$415,506,651,117$415,435,306,334.37$14,099$1,351.30+$415506.64M → NEXI
3$2,419,908,598,386,268$2,419,464,006,269,573.00$16,580$1,494.55+$2419908598.37M → NEXI
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$19,384$1,642.61+$13171697643084.44M → NEXI
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$22,535$1,794.70+$67004927492790120.00M → NEXI
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$26,063$1,950.00+$318562277003514871808.00M → NEXI
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$29,995$2,107.69+$1.415484168853553e+24M → NEXI
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$34,361$2,266.99+$5.878130573362507e+27M → NEXI
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$39,194$2,427.12+$2.2813793009840744e+31M → NEXI
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$44,525$2,587.35+$8.275235618773884e+34M → NEXI

NEXI vs RYLD: Complete Analysis 2026

NEXI — Stock

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Full NEXI Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this NEXI vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEXI vs SCHDNEXI vs JEPINEXI vs ONEXI vs KONEXI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.